We are live on ! Find out more
QTTB icon

Q32 Bio

42 hedge funds and large institutions have $336M invested in Q32 Bio in 2018 Q1 according to their latest regulatory filings, with 42 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

34.65% more ownership

Funds ownership: 0%34.65% (+35%)

Holders
42
Holders Change
+42
Holders Change %
% of All Funds
0.96%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
42
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

No sellers this quarter

QTTB Hedge Fund Activity: Q1 2018 in Review

42 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q1 2018, worth a combined $336M.

Buyers outnumbered sellers: 42 funds opened new QTTB positions and 0 closed out — a net gain of 42 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Deerfield Management, opening a new position worth an estimated $97.6M.

  • 42 institutional investors held Q32 Bio (QTTB) as of Q1 2018, up from 0 in Q4 2017.
  • Funds reported $336M of Q32 Bio stock for Q1 2018.
  • 42 funds opened new Q32 Bio positions in Q1 2018 and 0 closed out, a net change of +42 holders.
  • The largest Q32 Bio buyer in Q1 2018 was Deerfield Management, an estimated $97.6M added.

Based on aggregated 13F filings for Q1 2018.